Monoclonal Antibodies for Characterization of the Heterogeneity of Normal and Malignant Transitional Cells
- 1 April 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 137 (4) , 758-763
- https://doi.org/10.1016/s0022-5347(17)44205-4
Abstract
We present two monoclonal antibodies (mab), Mano 4/4 and 486 P3/12, directed against tumor-associated antigens of different subpopulations of transitional cell bladder carcinoma tumors. A detailed description is given concerning their reactivity patterns in an ELISA assay against different cell lines. Using immunohistochemical staining against normal bladder mucosa, mab Mano 4/4 reacts with distinct cells in the basal layer and mab 486 P 3/12 recognizes single cells in the superficial layer. Analysing different transitional-cell carcinomas, mab Mano 4/4 reacts with 17 of 20 and mab 486 P 3/12 with 17 of 19 bladder tumors. It is emphasized that both mabs may add new information in respect to a better characterization of the heterogeneity of bladder carcinoma. A biochemical characterization of the mabs and their corresponding antigens is given. Mab Mano 4/4 is directed against a 28 kD glycoprotein and mab 486 P 3/12 is reacting with a 200 kD glycoprotein belonging to the family of CEA-like proteins.This publication has 26 references indexed in Scilit:
- Chemotherapy and Human Bladder Carcinoma Transplanted into NMRI NU/NU MiceJournal of Urology, 1985
- A monoclonal antibody to human transitional‐cell carcinoma of the bladder cross‐reacting with a differentiation antigen of neutrophilic lineageInternational Journal of Cancer, 1985
- Monoclonal Antibodies to Human Urothelial Cell Lines and Hybrids: Production and CharacterizationJournal of Urology, 1985
- Murine Hybridoma Antibodies Against Human Transitional Carcinoma-Associated AntigensJournal of Urology, 1984
- The heterogeneous nature of metastatic neoplasms: Implications for the treatment of cancerUrology, 1984
- Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.Proceedings of the National Academy of Sciences, 1984
- The Value of Histologic Grading and Staging, Random Biopsies, Tumor and Bladder Mucosa Blood Group Antigens, in Predicting Progression of Superficial Bladder CancerEuropean Urology, 1984
- Hybridoma Antibodies Reactive with Human Bladder Carcinoma Cell Surface AntigensJournal of Urology, 1983
- Cell Surface A, B or O(H) Blood Group Antigens as an Indicator of Malignant Potential in Stage A Bladder CarcinomaJournal of Urology, 1980
- The Cell Surface Antigen A, B or O(h) as an Indicator of Malignant Potential in Stage a Bladder Carcinoma: Preliminary ReportJournal of Urology, 1978